FDA inspection

Aurisco Pharmaceutical Co., Ltd: FDA inspection ending Nov 15, 2013

FDA inspection 856482 · No Action Indicated (NAI) · Tiantai, Taizhou

Key facts

Inspection ID 856482
Firm Aurisco Pharmaceutical Co., Ltd
FEI number 3005793293
Address Badu Industrial Park, Zone
City Tiantai, Taizhou
Country China
Fiscal year 2014
Inspection end date Nov 15, 2013
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections